Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

CD47 Expression Serves as Predictive Biomarker for HER2+ Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Summary by targetedonc.com
New data reveals CD47 expression as a key biomarker for predicting evorpacept's effectiveness in treating HER2-positive metastatic breast cancer.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

4 Articles

targetedonc.comtargetedonc.com

CD47 Expression Serves as Predictive Biomarker for HER2+ Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

New data reveals CD47 expression as a key biomarker for predicting evorpacept's effectiveness in treating HER2-positive metastatic breast cancer.

Read Full Article
curetoday.comcuretoday.com

CD47 Protein May Predict Evorpacept Success in Metastatic Breast Cancer

Clinical trial data shows that the protein CD47 may predict how well evorpacept works for patients with metastatic breast cancer.

Read Full Article
Verdict HospitalVerdict Hospital
Reposted by
Clinical Trials ArenaClinical Trials Arena

ALX Oncology announces Phase Ib/II trial results for breast cancer

ALX Oncology has announced new data from a Phase Ib/II clinical trial of its CD47-inhibitor, evorpacept, combined with Jazz Pharmaceuticals’ Ziihera in heavily pretreated patients with HER2-mBC.The post ALX Oncology announces Phase Ib/II trial results for breast cancer appeared first on Hospital Management.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Clinical Trials Arena broke the news in on Monday, February 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Breast Cancer icon

Breast Cancer

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal